DEC
13

TUL Obtained Products Approval for Recombinant Human Insulin Product, Full Sights on the Multi-billion Market

NOV
13

TUL Obtained Products Approval for Two New Eye Drops Products

NOV
10

TUL Acquired FDA Approval for its Product, Planned to Enter US Market

SEP
09

The Group Recorded the Highest Ever Sales of HK$2.1B, Capture Opportunities Arising from National Policies to Foster Long Term Growth

MAY
04

New Medicine Specializes in Treatment of Influenza Virus Type A Obtained Production Approval

APR
19

Market Launch of Acetaminophen and Dextromethorphan Hydrobromide Oral Solution - New Medicine Specializes in Treatment of Influenza and Cough

APR
08

The United Laboratories International Holdings Limited Announces 2008 Annual Results

MAR
23

TUL's Products Acquired International Standard Accreditation Once Again Granted EU Certificate of Suitability